Stephanie Lovell - 27 May 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Director
Signature
/s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
27 May 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 17:20:45 UTC
Next filing
28 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +2,250 $0.000000 2,250 27 May 2021 Common Stock 2,250 $26.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to one-third of the shares subject to the option on March 22, 2022 and in equal monthly installments as to the remainder of the shares for two years thereafter.